The global anti-nuclear antibody testing market is at the forefront of modern immunology, providing the primary screening tool for identifying systemic autoimmune disorders. ANA tests detect autoantibodies that target the nucleus of a patient’s own healthy cells, serving as a critical indicator for conditions such as Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, and...